Login / Signup

Geographic and Demographic Representation in Industry-Sponsored, US-Based Clinical Trials of Systemic Lupus Erythematosus Therapies.

Joshua J SkydelReshma RamachandranSakinah C SuttiratanaJoseph R RossChristopher M BurnsJoshua D Wallach
Published in: The Journal of rheumatology (2024)
Keyphrases
  • systemic lupus erythematosus
  • clinical trial
  • disease activity
  • phase ii
  • open label
  • phase iii
  • double blind
  • study protocol
  • neural network
  • rheumatoid arthritis